Pyroptosis-Related Gene Signature Predicts Prognosis and Response to Immunotherapy and Medication in Pediatric and Young Adult Osteosarcoma Patients

Chaofan Guo,Xin Yang,Lijun Li

DOI: https://doi.org/10.2147/jir.s440425

IF: 4.5

2024-01-21

Journal of Inflammation Research

Abstract:Chaofan Guo, 1, 2, &ast Xin Yang, 3, &ast Lijun Li 1, 2 1 Department of Orthopedics, Shanxi Provincial People's Hospital, Taiyuan, Shanxi Province, People's Republic of China; 2 Department of Spine Surgery, Fifth Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China; 3 Department of Neurosurgery, Chongqing Fourth People's Hospital, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lijun Li, Department of Orthopedics, Shanxi Provincial People's Hospital, Shuangtasi Street No. 29, Taiyuan, 030012, People's Republic of China, Tel +86 0351-4960081, Email Purpose: Pyroptosis, a new form of inflammatory programmed cell death, has recently gained attention. However, the impact of the expression levels of pyroptosis-related genes (PRGs) on the overall survival (OS) of osteosarcoma patients remains unclear. This study aims to investigate the impact of the expression levels of PRGs on the OS of pediatric and young adult patients with osteosarcoma. Patients and Methods: Transcriptome matrix datasets of normal muscle or skeletal tissues from the Genotype-Tissue Expression (GTEx) project and osteosarcoma specimen the National Cancer Institute's (NCI) Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database were used to identify pyroptosis-related genes (PRGs) associated with prognosis. The National Center for Biotechnology Information's (NCBI) GSE21257 dataset was employed to validate the predictive value of the pyroptosis-related signature (PRS). Additionally, reverse transcription polymerase chain reaction (RT-qPCR) experiment was performed in normal and osteosarcoma cell lines. Results: The study identified 18 differentially expressed PRGs (DEPRGs) between normal muscle or skeletal tissues and tumor samples. Multiple machine learning techniques were used to select PRGs, resulting in the identification of four hub PRGs. A PRS-score was calculated for each sample based on the expression of these four hub PRGs, and samples were categorized into low and high PRS-score level groups. It was confirmed that metastatic status and PRS-score level are independent prognostic predictors. A nomogram model for predicting OS of osteosarcoma patients was constructed. Single-cell RNA-sequencing data display the expression patterns of the hub PRGs. RT-qPCR data results were found to be consistent with the differential expression analysis performed on TARGET and GTEx samples. Conclusion: The study developed a novel pyroptosis-related gene signature that can stratify pediatric and young adult osteosarcoma patients into different risk groups, thus predicting their response to immunotherapy and chemotherapy. Keywords: TARGET, nomogram model, immune microenvironment, drug sensitivity Osteosarcoma, the most common primary malignant bone tumour among all ages, often occurs in children and adolescents. It accounts for around 5% of all childhood cancers. 1 The most frequent primary sites of osteosarcoma are distal femur, proximal tibia, and proximal humerus. 2 When the cancer is diagnosed, 15–20% of patients already have shown macroscopic evidence of metastases, most (85–90%) of which occur in their lungs. 3,4 Before the 1970s, surgical resection is the primary treatment for osteosarcoma. Notably, the introduction of chemotherapy since the 1970s has tremendously improved long-term survival rates of patients with osteosarcoma, which have risen from less than 20% to 65–70%. 3 Programmed cell death (PCD) is an essential part of human development and tissue homeostasis enabling the removal of unwanted cells. 5 Pyroptosis, a newly-discovered type of PCD, 6 is a highly inflammatory process in which cells lose their cytomembrane intactness. 7 This form of cell death, characterized by swelling, bubble-like protrusions, and shedding of membrane vesicles, leads to the release of intracellular contents and entry of annexin V. 5,8 Recent studies have revealed the critical role of pyroptosis in tumour biology, particularly in osteosarcoma, where it has been associated with patient survival and disease progression. Additionally, the role of pyroptosis in osteosarcoma development, although not fully understood, is becoming increasingly recognized, emphasizing the need for further research in this area. 9,10 Pyroptosis is mediated by gasdermin (GSDM) proteins, triggering immune cell activation and infiltration. 11–13 The expression of GSDMD, in particular, is essential for the anti-tumour function of CD8 + T cells, 14</sup -Abstract Truncated-

immunology